The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.
Open accessAbstract
According to classical models of drug-receptor interactions, competitive antagonists share with agonists the ability to bind to a common site on the receptor molecule. However, they are different from agonists, as they cannot trigger the "stimulus" that leads to biological responses--i.e., they lack intrinsic activity. For those receptors whose signals are transduced to effector systems by GTP-binding regulatory proteins (G proteins), a mechanistic equivalent of such a stimulus is an increased ability of agonist-bound receptor to accelerate nucleotide exchange and thus GTPase activity on the G-protein molecule. Here we show that for a member of this family of receptors (delta opioid receptors in membranes of NG108-15 neuroblastoma-glioma cells), two types of competitive antagonists can be distinguished. One type has no intrinsic activity, since it neither stimulates nor inhibits the GTPase activity of G proteins and its apparent affinity for the receptor is not altered by pertussis toxin-mediated uncoupling of receptor and G protein. The second type, however, can inhibit GTPase and thus exhibits negative intrinsic activity; its affinity for receptors is increased following uncoupling from G proteins. The existence of antagonists with negative intrinsic activity may be a general feature of several classes of neurotransmitters or hormone receptors and calls for a reevaluation of biological effects produced by competitive antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
The role of hormone receptors and GTP-regulatory proteins in membrane transduction
Rodbell, M. (1980) · Nature · doi:10.1038/284017a0 · Cited by 1,749
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
GTP-binding proteins couple cardiac muscarinic receptors to a K channel
Pfaffinger, P. J., Martin, J. M., Hunter, D. D., Nathanson, N. M., & Hille, B. (1985) · Nature · doi:10.1038/317536a0 · Cited by 862
Roles of G protein subunits in transmembrane signalling
Neer, E. J., & Clapham, D. E. (1988) · Nature · doi:10.1038/333129a0 · Cited by 790
Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes
Cassel, D., & Selinger, Z. (1976) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(76)90206-0 · Cited by 619
Interaction of Convulsive Ligands with Benzodiazepine Receptors
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., & Petersen, E. N. (1982) · Science · doi:10.1126/science.6281892 · Cited by 547
Cited by
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Gether, U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0390 · Cited by 1,263
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Colquhoun, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702164 · Cited by 881
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Waldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Opioid receptor-coupled second messenger systems
Childers, S. R. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90154-4 · Cited by 466
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 461
Historical review: A brief history and personal retrospective of seven-transmembrane receptors
Lefkowitz, R. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.006 · Cited by 417
Bond, R. A., Leff, P., Johnson, T. D., Milano, C. A., Rockman, H. A., McMinn, T. R., Apparsundaram, S., Hyek, M. F., Kenakin, T. P., Allen, L. F., et al. (1995) · Nature · doi:10.1038/374272a0 · Cited by 416
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Inverse agonist activity of beta-adrenergic antagonists.
Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., & Bouvier, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10022-9 · Cited by 372
Drug Efficacy at G Protein–Coupled Receptors
Kenakin, T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091401.113012 · Cited by 316
The [35S]GTPγS binding assay: approaches and applications in pharmacology
Harrison, C., & Traynor, J. R. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.07.005 · Cited by 302
Structural Instability of a Constitutively Active G Protein-coupled Receptor
Gether, U., Seifert, R., Ballesteros, J. A., Sanders-Bush, E., Weinstein, H., & Kobilka, B. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2587 · Cited by 295
Fluorescent Labeling of Purified β2 Adrenergic Receptor
Gether, U., Lin, S., & Kobilka, B. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28268 · Cited by 278
Joly, C., Gomeza, J., Brabet, I., Curry, K., Bockaert, J., & Pin, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03970.1995 · Cited by 278
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi, M., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46876-7 · Cited by 265
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Keov, P., Sexton, P. M., & Christopoulos, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.010 · Cited by 265
Efficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
OPIOID RECEPTOR SIGNALLING MECHANISMS
Connor, M., & Christie, M. J. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03049.x · Cited by 258
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., & Milligan, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008902200 · Cited by 257
Barker, E. L., Westphal, R. S., Schmidt, D., & Sanders-Bush, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32625-x · Cited by 254
Constitutive μ-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence
Corder, G., Doolen, S., Donahue, R. R., Winter, M. K., Jutras, B. L., He, Y., Hu, X., Wieskopf, J. S., Mogil, J. S., Storm, D. R., et al. (2013) · Science · doi:10.1126/science.1239403 · Cited by 240
Metadata
- Authors
- Costa, T., & Herz, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-10
- Volume
- 86
- Issue
- 19
- Pages
- 7321-7325
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1964191104
- Cited by
- 536
- References
- 27
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.